HIV Grand Rounds - Archived Pilot Series

GrandRound_ArchivedPilotSeries.jpg

Content Links:

Program Overview
Target Audience
Commercial Support Acknowledgement
Learning Objectives
Course Directors
Faculty
Archived Pilot Series Catalog
Frequently Asked Questions (FAQs)

Discussion Forum
Hardware/Software Notice
Method of Participation and Request for Credit
Accreditation and Credit Designation Statements
Disclosure of Conflict of Interest 
Disclosure of Unlabeled Use
Disclaimer 
Return to Program Home Page

 

Program Overview:

Mirroring the academic grand rounds programs, these CME programs combine traditional academic grand rounds with the innovation and convenience of telemedicine. This weekly webinar program, broadcast from the Perelman School of Medicine at the University of Pennsylvania, and delivered by top experts in the field, covers a wide range of topics involved with the clinical care of patients with HIV/AIDS.

The one-hour presentations will be designed to be immediately relevant to practicing HIV clinicians and many will be case-based. The final 10 minutes of each one-hour program will consist of a live question and answer period with the presenting faculty member available to answer questions asked by participants who attend in person or via the Internet. These weekly grand rounds programs are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their HIV-positive patients.

Back to Top

Target Audience:

This activity has been designed to meet the educational needs of physicians, other health care providers, and pharmacists who diagnose and manage patients with HIV/AIDS.

Back to Top  

Commercial Support Acknowledgement:

This activity is supported by an unrestricted educational grant from Gilead Sciences and Janssen Therapeutics.

Back to Top

Learning Objectives:

Upon completion of the program, participants should be able to:

  • List the important factors that play a role in ARV therapy success;
  • Explain the role that drug adverse events, drug pharmacokinetics and patient adherence play in achieving ARV success and avoiding morbidity and mortality;
  • Describe the important opportunistic infections and co-morbidities that may affect HIV-positive patients and increase their risk for morbidity and mortality;
  • Discuss the importance of individualizing the care of each HIV-positive patient.
Back to Top

Course Directors:

JohnBartlett

John Bartlett, MD
Professor of Medicine,
Johns Hopkins School of Medicine
Baltimore, Maryland

CalvinCohen

Calvin J. Cohen, MD, MS
Research Director,
CRI New England
Clinical Instructor,
Harvard Medical School
Boston, Massachusetts

Ian Frank Ian Frank, MD
Professor of Medicine,
Director, Antiretroviral Clinical Research
University of Pennsylvania
Philadelphia, Pennsylvania
   
Back to Top

Faculty:


Frederick Altice, MD
Professor of Medicine,
Director of Clinical Research and Community Research
Yale University School of Medicine
Section of Infectious Diseases, AIDS Program
New Haven, Connecticut

Gregory Melikian, PhD
Professor, Department of Pediatrics,
Division of Infectious Diseases
Emory University
Atlanta, Georgia

Gregory Bisson, MD
Assistant Professor of Medicine,
Infectious Diseases Division
University of Pennsylvania School of Medicine
Assistant Professor of Epidemiology
Center for Clinical Epidemiology & Biostatistics
Philadelphia, Pennsylvania

David Metzger, Ph.D.
Research Professor of Social Policy in Psychiatry
Director, HIV Prevention Research Division
University of Pennsylvania
Department of Psychiatry
Philadelphia, Pennsylvania

Jason Brenchley, PhD
Investigator, Molecular Microbiology
Viral Pathogenesis and Vaccine
National Institute for Allergies and Infectious Diseases
Bethesda, Maryland

Karam Mounzer, MD
Medical Director,
The Jonathan LAX Center
Philadelphia FIGHT
Philadelphia, Pennsylvania

Todd T. Brown, MD
Assistant Professor of Medicine
Division of Endocrinology and Metabolism
Johns Hopkins University
Baltimore, Maryland

K. Rajender Reddy, MD
Professor of Medicine
Professor of Medicine in Surgery
Director of Hepatology
Medical Director of Liver Transplantation
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
 Back to Top  

Richard A. Elion, MD
Associate Professor of Clinical Medicine,
George Washington University Medical Center
Research Director, Director,
Whitman-Walker Clinic
Washington, DC

Deirdre Sawinski, MD
Assistant Professor of Medicine,
Renal, Electrolyte and Hypertension Division
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania

Joseph Eron, MD
Professor,
University of North Carolina
School of Medicine
Chapel Hill, North Carolina

David M. Simpson MD
Professor of Neurology
Director, Clinical Neurophysiology Laboratories
Director, Neuro-AIDS Program
Mount Sinai Medical Center
New York, New York

Joseph Garland, MD
Fellow,
Division of Infectious Diseases
Department of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

Mark Sulkowski, MD

Associate Professor of Medicine and Medical Director,
Viral Hepatitis Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

Kelly Gebo MD
Associate Professor of Medicine, Epidemiology
Johns Hopkins University
School of Medicine
Baltimore, Maryand

Pablo Tebas, MD
Director, AIDS Clinical Trials Unit
University of Pennsylvania
School of Medicine
Philadelphia, Pennsylvania
 Back to Top  

Robert Gross, MD
Associate Professor of Medicine (Infectious Diseases)
Associate Professor of Epidemiology
Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania

Glenn Treisman, MD
Professor of Psychiatry,
Department of Psychiatry and Behavioral Sciences,
Professor of Medicine,
Department of Internal Medicine,
Johns Hopkins University School of Medicine
Director, AIDS Psychiatry Service,
Co-director, Pain Treatment Program, Johns Hopkins Medicine
Baltimore, Maryland

Trevor Hawkins, MD
Associate Professor,
University of New Mexico
Medical Director,
Southwest CARE Center
Santa Fe, New Mexico

Christopher Vinnard, MD
Fellow, Infectious Diseases
University of Pennsylvania,
School of Medicine
Philadelphia, Pennsylvania

Jay Kostman, MD
Clinical Associate Professor of Medicine
Division of Infectious Diseases
Chief, Infectious Diseases Division,
Penn Presbyterian Medical Center
University of Pennsylvania
Philadelphia, Pennsylvania

Amy Vittor, MD, PhD
Fellow, Infectious Diseases
University of Pennsylvania,
School of Medicine
Philadelphia, Pennsylvania

Carrie Kovarik, MD
Assistant Professor,
Departments of Dermatology and Infectious Diseases
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania   

Baligh Yehia, MD

Fellow, Infectious Diseases
University of Pennsylvania,
School of Medicine
Philadelphia, Pennsylvania


Andrew Zolopa, MD
Associate Professor of Medicine,
Division of Infectious Diseases
Stanford University School of Medicine
Stanford, California
Back to Top

Archived Pilot Series Catalog:

Click on the week, speaker and topic below to register and launch the on-demand program.

Back to Top


Week 1: September 29, 2010
Speaker: Cal Cohen, MD
Topic: Review of the Evidence: Do We Already Know the Answer Posed in the START Trial?


**Please note the introductory four-minutes of Dr. Cohen's talk was not recorded

This program is no longer available for CME credit but will remain available for viewing on demand.


Week 2: October 6, 2010
Speaker: John Bartlett, MD
Topic: Antiretroviral Therapy: What to Start?

This program is no longer available for CME credit but will remain available for viewing on demand.


Week 3: October 13, 2010
Speaker: Ian Frank, MD and Panel
Topic: Case Studies from the Hospital of the University of Pennsylvania

 This program is no longer available for CME credit but will remain available for viewing on demand.


Week 4: October 20, 2010
Speaker: Frederick Altice, MD
Topic: Special Challenges: Clinical Management of the HIV-infected Drug User

This program is no longer available for CME credit but will remain available for viewing on demand.


Week 5: October 27, 2010
Speaker: Glenn Treisman, MD
Topic: The Psychiatry of AIDS: A Guide to Diagnosis and Treatment

This program is no longer available for CME credit but will remain available for viewing on demand.


Week 6: November 3, 2010
Speaker, Andrew Zolopa, MD
Topic: HIV Drug Resistance: Does it Matter Anymore?

This program is no longer available for CME credit but will remain available for viewing on demand.

 Back to Top  

Week 7: November 10, 2010
Speaker Pablo Tebas, MD
Topic: Metabolic Complications of ARV and Their Management

This program is no longer available for CME credit but will remain available for viewing on demand.


Week 8: November 17, 2010
Speaker: Gregory Melikian, PhD
Topic: Imaging Single Retrovirus Entry and Fusion

 available for CME credit but will remain available for viewing on demand.


Week 9: December 1, 2010
Speaker: Robert Gross, MD
Topic: Adherence and Antiretroviral Therapy

This program is no longer available for CME credit but will remain available for viewing on demand.


Week 10: December 8, 2010
Speaker: Todd T. Brown, MD
Topic: Osteoporosis in the HIV-Infected Patient

This program is no longer available for CME credit but will remain available for viewing on demand.


Week 11: December 16, 2010
Speaker: Jason Brenchley, PhD
Topic: Mechanisms Underlying Different Outcomes in Primate Lentiviral Infections


This program is no longer available for CME credit but will remain available for viewing on demand.


Week 12: January 12, 2011
Panel: Pablo Tebas, MD, Karam Mounzer, MD, Baligh Yehia, MD, and Amy Vittor, MD, PhD
Topic: Case Studies from the Hospital of the University of Pennsylvania

This program is no longer available for CME credit but will remain available for viewing on demand.

 Back to Top  

Week 13: January 19, 2011
Speaker: David Simpson, MD
Topic: Neurological Complications in HIV/AIDS

 

This program is no longer available for CME credit but will remain available for viewing on demand.


Week 14: January 26, 2011
Speaker: Richard Elion, MD
Topic: Treatment as Prevention

This program is no longer available for CME credit but will remain available for viewing on demand.


Week 15: February 2, 2011
Speaker: Joe Eron, MD
Topic: Antiretroviral Therapy: New Drugs and New Strategies

This program is no longer available for CME credit but will remain available for viewing on demand.


Week 16: February 9, 2011
Speaker: Deirdre Sawinski, MD
Topic: Kidney Disease and Transplant in HIV+ Patients

This program is no longer available for CME credit but will remain available for viewing on demand.


Week 17: February 16, 2011
Speaker David Metzger, PhD
Topic: Substance Abuse Treatment as HIV Prevention

This program is no longer available for CME credit but will remain available for viewing on demand.


Week 18: February 23, 2011
Speaker: Trevor Hawkins, MD
Topic: CNS Infections Associated with HIV Disease

This program is no longer available for CME credit but will remain available for viewing on demand.

 Back to Top  

Week 19: March 9, 2011
Speaker: Ian Frank, MD
Topic: An Update from the 2011 Conference on Retrovirus and Opportunistic Infections (CROI)

This program is no longer available for CME credit but will remain available for viewing on demand.


Week 20: March 16, 2011
Speakers: Ian Frank, MD, Gregory Bisson, MD, Dierdre Sawinski, MD and Christopher Vinnard, MD
Topic: HIV Case Studies from the Hospital of the University of Pennsylvania

This program is no longer available for CME credit but will remain available for viewing on demand.


Week 21: March 23, 2011
Speaker: Kelly Gebo, MD
Topic: The HIV Research Network: Lessons learned from a multi-site study

This program is no longer available for CME credit but will remain available for viewing on demand.


Week 22: March 30, 2011
Speaker: Greg Bisson, MD
Topic: Tuberculosis and HIV: Epidemiology, prevention and when to start antiretroviral therapy


This program is no longer available for CME credit but will remain available for viewing on demand.


Week 23: April 6, 2011
Speaker: Carrie Kavorik, MD
Topic: Update in HIV-related Dermatology

 

This program is no longer available for CME credit but will remain available for viewing on demand.


Week 24: April 13, 2011
Speaker: Mark Sulkowski, MD
Topic: Strategies for Managing HIV and Hepatitis C Virus Coinfection

This program is no longer available for CME credit but will remain available for viewing on demand.

 Back to Top  

Week 25: April 27, 2011
Speaker: Calvin Cohen, MD
Topic: Challenging the Three AVRs Per Day Paradigm

This program is no longer available for CME credit but will remain available for viewing on demand.


Week 26: May 4, 2011
Speaker: Rajender Reddy
Topic: Updates on Current Studies of HCV: Post-EASL

This program is no longer available for CME credit but will remain available for viewing on demand.

Back to Top

Frequently Asked Questions (FAQs):

  • Above, on the right hand side, is a tab labeled "FAQS".
  • Viewer questions and faculty responses regarding the enduring programs will be posted here for participant review.
  • You may sort through these by selecting the week you are interested in viewing.
Back to Top

Discussion Forum:

  • Above, on the right hand side, is a tab labeled "View/Join Discussion".
  • Participants may initiate, join, or read discussion forums in this location.
Back to Top

Hardware/Software Notice:

You will need Internet to participate in this activity.

Back to Top

Method of Participation and Request for Credit:

There are no fees for participating and receiving CME credit for this activity. During the period specified for each program above, participants must read the learning objectives and faculty disclosures and study the educational activity.

If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on http://www.cmeuniversity.com/. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID (specified for each program above). Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately.

Back to Top

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Annenberg Center for Health Sciences Center at Eisenhower and ViralEd.  The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Back to Top

Credit Designation Statement:

The Annenberg Center for Health Sciences at Eisenhower designates enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Back to Top

Disclosure of Conflicts of Interest:

The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by the Annenberg Center for Health Sciences at Eisenhower for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Dr. Frederick Altice:

  • Fees for non-CME/CE Services:Bristol-Myers Squibb; Merck; Genentech; Tibotec
  • Contracted Research: Boehringer Ingelheim

Dr. John Bartlett:

  • Reports no real or apparent conflicts of interest.

Dr. Gregory Bisson:

  • Reports no real or apparent conflicts of interest.

Dr. Jason Brenchley:

  • Reports no real or apparent conflicts of interest.

 Back to Top

Dr. Todd Brown

  • Consulting Fees: Gilead; Tibotec; BMS; EMD-Serono; Theratechnologies

Dr. Calvin Cohen:

  • Contracted Research: Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec; ViiV
  • Consulting Fees: Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec; Abbott
  • Speakers Bureau: Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec

Dr. Richard Elion:

  • Contracted Research: BMS, Gilead, GSK, Tibotec
  • Consulting Fees: BMS, Gilead, GSK, Tibotec
  • Speakers Bureau: BMS, Gilead, GSK, Merck, Rapid, Tibotec

Dr. Joseph Eron:

  • Contracted Research: Merck, GlaxoSmithKline, TaiMed
  • Consulting Fees: Merck, Avexa, BMS, GSK/ViiV, Tibotec, Virco Laboratories, Pfizer, Tobira, Argos

 Back to Top

Dr. Ian Frank:

  • Contracted Research: GlaxoSmithKline; Merck & Co.
  • Consulting Fees: Gilead; Tibotec; Bristol-Myers Squibb
  • Speakers Bureau: Gilead; Tibotec

Dr. Joseph Garland:

  • Reports no real or apparent conflicts of interest.

Dr. Kelly Gebo:

  • Consulting Fees and Contracted Research: Tibotec

Dr. Robert Gross:

  • Contracted Research: Bristol-Myers Squibb

Back to Top

Dr. Trevor Hawkins:

  • Consulting Fees: Gilead Sciences; Tibotec; Bristol-Myers Squibb; Merck
  • Fees for Non-CME/CE Services: Gilead Sciences; Tibotec; Bristol-Myers Squibb; Merck

Dr. Jay Kostman

  • Reports no real or apparent conflicts of interest.

Dr. Carrie Kovarik

  • Reports no real or apparent conflicts of interest.

Dr. Gregory Melikian

  • Reports no real or apparent conflicts of interest.

Dr. David Metzger

  • Reports no real or apparent conflicts of interest.

 Back to Top

Dr. Karam Mounzer

  • Consulting Fees: Abbott, Tibotec, Gilead, Merck
  • Fees for Non-CME/CE Services: Abbott, Tibotec, Gilead, Merck, BMS
  • Contracted Research: GSK, Gilead, Tibotec, Merck

Dr. Deirdre Sawinski

  • Reports no real or apparent conflicts of interest.

Dr. Rajender Reddy

  • Consulting Fees: Vertex, Tibotec, Genentech, Merck, Gilead
  • Contracted Research: Vertex, Genentech, Merck, Gilead, BMS, Boehringer Ingelheim

Dr. David Simpson:

  • Consulting Fees: NeurogesX; Eli Lilly; Pfizer; Merck; Astellas; Gilead
  • Fees for Non-CME/CE Services: Eli Lilly; Astellas
  • Contracted Research: NeurogesX; Pfizer; Eli Lilly

 Back to Top

Dr. Mark Sulkowski:

  • Consulting Fees: Merck, Vertex, Tibotec, BMS, Gilead, Roche, Pharmasset, BIPI, Abbott, Novartis
  • Contracted Research: Merck, Vertex, Tibotec, BMS, Gilead, Roche, Pharmasset, BIPI, Abbott, Novartis

Dr. Pablo Tebas:

  • Fees for Non-CME/CE Services: GlaxoSmithKline; Merck; Pfizer; Tibotec

Dr. Glenn Treisman:

  • Speakers Bureau: Boehringer Ingelheim; Abbott

Dr. Christopher Vinnard:

  • Reports no real or apparent

Dr. Amy Vittor:

  • Reports no real or apparent conflicts of interest.

 Back to Top

Dr. Baligh Yehia

  • Reports no real or apparent conflicts of interest.

Dr. Andrew Zolopa:

  • Consulting Fees: Gilead Sciences; Tibotec; BMS
  • Contracted Research: Gilead Sciences; Pfizer; Bristol-Myers Squibb; VIRxSys

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following planners and managers, Jan Hixon, RN, BSN, MA; Trace Hutchison, PharmD; Julia Kimball, RN, BSN; Samantha Mattiucci, PharmD; Jan Schultz, RN, MSN, CCMEP; Patricia Staples, MSN, NP-C, CCRN and Gordon West, PhD, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Back to Top

Disclosure of Unlabeled Use:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. ViralEd, LLC, the Annenberg Center for Health Sciences at Eisenhower, the Perelman School of Medicine at the University of Pennsylvania, Gilead Sciences and Janssen Therapeutics do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of ViralEd, LLC, the Annenberg Center for Health Sciences at Eisenhower, the Perelman School of Medicine at the University of Pennsylvania, Gilead Sciences and  Janssen Therapeutics. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Back to Top

Disclaimer:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Back to Top

You may contact Richard Gordon by phone at 1-856-506-5790 or by email at Rgordon@viraled.com for additional assistance.

We look forward to bringing the highest-quality CME directly to you.

VE logo 300px Annenberg_Centered_logo
GrandRoundsUpenn_ReturntoMainPrgm_button
Recommend this page to a friend! Prepare to print

Share this page:

Get link code to this page                     


Back to Top